{"slideshow_credits": null, "snippet": "William A. Ackman said the drug company Valeant was undervalued and had potential but its decline had affected his firm, Pershing Square.", "abstract": "Pershing Square Capital Management owner William A Ackman admits he underestimated complexities surrounding Valeant Pharmaceuticals; Ackman's hedge fund was negatively impacted when troubled drug firm's stock fell sharply last quarter. ", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "qualifier": "Jr", "rank": 1, "firstname": "Landon", "role": "reported", "organization": ""}], "original": "By LANDON THOMAS Jr"}, "web_url": "http://www.nytimes.com/2016/04/07/business/dealbook/ackman-defends-pershing-squares-large-stake-in-valeant.html", "lead_paragraph": "William A. Ackman said the drug company Valeant was undervalued and had potential but its decline had affected his firm, Pershing Square.", "headline": {"main": "Ackman Defends Pershing Square\u2019s Large Stake in Valeant", "print_headline": "Business Briefing; Ackman Defends Holding in Beleaguered Valeant"}, "_id": "57054e9638f0d86865ca518f", "word_count": "510", "multimedia": [{"height": 126, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 392, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/07/business/07db-ackman/07db-ackman-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "392"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/07/business/07db-ackman/07db-ackman-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-04-07T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Pershing Square Capital Management", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Ackman, William A", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Hedge Funds", "is_major": "N", "rank": "4"}, {"name": "persons", "value": "Pearson, John Michael (1959- )", "is_major": "N", "rank": "5"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}